Hls Therapeutics (TSX: HLS)
CA$4.75
(2.2%)
CA$0.10
Price as of May 3, 2024, 2:06 p.m. ET
Hls Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Hls Therapeutics Company Info
HLS Therapeutics, Inc. operates as a pharmaceutical company. It focuses on clinically differentiated pharmaceutical products in the specialty central nervous system (CNS) and cardiovascular (CV) markets. The company was founded by Gregory Gubitz and Gilbert Godin on March 12, 2018 and is headquartered in Etobicoke, Canada.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.